文献速递免疫规划传染病防控与疫情报告

日本引入b型流感嗜血杆菌疫苗后儿童侵袭性流感嗜血杆菌病全国监测

A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
PubMed 文献 · Vaccine · 2018-08-16

研究基于日本10个县2008-2017年主动人群监测,评估Hib疫苗纳入常规免疫前后儿童侵袭性流感嗜血杆菌病变化。2013-2017年<5岁儿童病例较2008-2012年下降93%(IRR 0.07,95%CI 0.05-0.10,p<0.001)。2014年后未分离到Hib株,但不可分型和f型成为病因。

要点

  • 2013-2017年<5岁儿童侵袭性Hib病较2008-2012年下降93%(IRR 0.07)。
  • 2014年后侵袭性病例中未再分离到Hib株。
  • 不可分型流感嗜血杆菌和f型成为Hib疫苗时代侵袭性病例病因。

核心结论

  • 政府补贴Hib疫苗后,研究人群中侵袭性Hib病例急剧下降;需持续监测疫苗效果及新发侵袭性荚膜型。

研究设计与样本

  • 2008-2017年在日本10个县(覆盖约23%日本总人口)开展基于人群的主动监测,纳入培养确诊的儿童侵袭性流感嗜血杆菌感染。
  • 使用标准化病例报告表记录临床数据,检测分离株荚膜型和抗菌药物敏感性。
  • 计算发病率比(IRR)及置信区间(CI),比较国家常规Hib疫苗免疫规划引入前5年与引入后数据。

主要发现

  • 10年研究期间共发现566例侵袭性流感嗜血杆菌病病例,其中脑膜炎336例。
  • 2013-2017年<5岁儿童侵袭性流感嗜血杆菌病平均病例数较2008-2012年下降93%(IRR 0.07,95%CI 0.05-0.10,p<0.001)。
  • 2014年后侵袭性流感嗜血杆菌病病例中未分离到Hib株;Hib疫苗时代<5岁儿童侵袭性病例病原包括不可分型流感嗜血杆菌和f型。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Haemophilus influenzae type b (Hib) vaccine was introduced as a voluntary vaccine in December 2008 and was included in the national routine immunization program in April 2013 in Japan. Currently, no nationwide data are available to evaluate the effectiveness of Hib vaccine in Japan. METHODS: To evaluate the effectiveness of Hib vaccine in Japan, nationwide active population-based surveillance of culture-proven invasive infections caused by H. influenzae in children was performed in 2008-2017 in 10 prefectures in Japan (covering approximately 23% of the total Japanese population). Clinical data were recorded on a standardized case report form. Capsular type and antimicrobial susceptibility of the H. influenzae isolates were examined. The incidence rate ratio (IRR) and its confidence interval (CI) were calculated to compare data from 5 years before and that from after the introduction of the national routine Hib vaccine immunization program. RESULTS: During the 10-year study period, 566 invasive H. influenzae disease cases including 336 meningitis cases were identified. The average number of invasive H. influenzae disease cases among children <5 years of age during 2013-2017 decreased by 93% (IRR: 0.07, 95%CI 0.05-0.10, p < 0.001) compared with those occurring during 2008-2012. Hib strains have not been isolated from invasive H. influenzae disease cases since 2014; however, non-typeable H. influenzae and H. influenzae type f isolates have been noted as causes of invasive H. influenzae diseases among children <5 years in the post-Hib vaccine era. CONCLUSIONS: After the governmental subsidization of the Hib vaccine, invasive Hib disease cases decreased dramatically in the study population, as per our surveillance. Continuous surveillance is necessary to monitor the effectiveness of Hib vaccine and for detecting any emerging invasive capsular types.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Suga S, Ishiwada N, Sasaki Y, et al. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan. Vaccine. 2018. PMID: 30122645. doi:10.1016/j.vaccine.2018.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。